E-bulletin - 23 April 2024
For reasons beyond the control of the applicant, the approval of the active substance/product type combination listed below was likely to expire before a decision could be taken on its renewal under the EU Biocidal Products Regulation (EU BPR). To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry date of the following approval. This affects Northern Ireland (NI):
- magnesium phosphide (Magnesium phosphide releasing phosphine (Trimagnesium diphosphide)) (CAS 12057-74-8 EC 235-023-7) in product type 18 – From 31 July 2024 to 31 January 2026
If you want to supply new biocidal products containing this/these active substance, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide a separate update on the renewal decision when relevant.
E-bulletin - 13 March 2024
For reasons beyond the control of the applicants, the approvals of the active substance/product type combinations listed below were likely to expire before a decision could be taken on their renewal under the EU Biocidal Products Regulation (EU BPR). To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry dates of the following approvals. This affects Northern Ireland (NI):
- Disodium tetraborate, pentahydrate (CAS 12179-04-3 EC 215-540-4 ) in product type 8 – From 28 February 2024 to 31 August 2026
- Boric acid (CAS 10043-35-3 EC 233-139-2 ) in product type 8 – From 28 February 2024 to 31 August 2026
If you want to supply new biocidal products containing these active substances, you can still apply for EU BPR product authorisation via the following link:
New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide separate updates on the renewal decisions when relevant.
Update - 18 December 2023
For reasons beyond the control of the applicant, the approval of the active substance/product type combination listed below was likely to expire before a decision could be taken on its renewal under the EU Biocidal Products Regulation (EU BPR). To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry date of the following approval. This affects Northern Ireland (NI):
- Hydrochloric acid (CAS 7647-01-0 EC 231-595-7) in product type 02 – From 30 April 2024 to 31 October 2026
If you want to supply new biocidal products containing this active substance, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide a separate update on the renewal decision when relevant.
New Update
Active substance expiry dates postponed whilst the renewal evaluation is completed in the EU.
For reasons beyond the control of the applicants, the approvals of the active substance/product type combinations listed below were likely to expire before a decision could be taken on their renewal under the EU BPR.
To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approvals until the following dates. This affects NI:
- 4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) (CAS 64359-81-5 EC 264-843-8) in product type 8
31 December 2025 - (2E)-1-[(6-chloropyridin-3-yl) methyl]-N-nitroimidazolidin-2- imine (Imidacloprid) (CAS 138261-41-3 EC 428-040-8) in product type 18
31 December 2025
If you want to supply new biocidal products containing these active substances, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide separate updates on the renewal decisions when relevant.
For further information in relation to Product Authorisation please follow the link below:
New Update
Active substance expiry date postponed whilst the renewal evaluation is completed in the EU.
For reasons beyond the control of the applicant, the approval of the active substance/product type combination listed below was likely to expire before a decision could be taken on its renewal under the EU Biocidal Products Regulation (EU BPR). To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approval until the following date. This affects Northern Ireland (NI):
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 8 – 31 December 2023
If you want to supply new biocidal products containing this active substance, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE will provide a separate update on the renewal decision when relevant.
For more information please see the following link:
Product authorisation - (HSE GB website)
New Update
Active substance expiry dates postponed whilst the renewal evaluation is completed in the EU.
For reasons beyond the control of the applicants, the approvals of the active substance/product type combinations listed below were likely to expire before a decision could be taken on their renewal under the EU Biocidal Products Regulation (EU BPR). To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approvals until the following dates. This affects Northern Ireland (NI):
- Acrylaldehyde (Acrolein) (CAS 107-02-8 EC 203-453-4) in product type 12 – 28 February 2025
- Spinosad as a mixture of 50-95 % spinosyn A and 5-50 % spinosyn D (Spinosad) (CAS 168316-95-8 EC 434-300-1) in product type 18 – 30 April 2025
- medetomidine (CAS 86347-14-0 EC n/a) in product type 21 – 30 June 2025
- Reaction mass of N,N- Didecyl-N,N-dimethylammonium Carbonate and N,N-Didecyl-N,N-dimethylammonium Bicarbonate (DDACarbonate) (CAS 894406-76-9 EC 451-900-9) in product type 8 – 30 June 2025
- 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 8 – 31 July 2025
- 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol (Tebuconazole) (CAS 107534-96-3 EC 403-640-2) in product type 8 – 30 June 2026
- 3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether (Etofenprox) (CAS 80844-07-1 EC 407-980-2) in product type 8 – 31 October 2026
- Cyclohexylhydroxydiazene 1-oxide, potassium salt (K-HDO) (CAS 66603-10-9 EC n/a) in product type 8 – 31 December 2026
If you want to supply new biocidal products containing these active substances, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE (GB) will provide separate updates on the renewal decisions when relevant.
For more information please see the following link:
New Update
Active substance expiry dates postponed whilst the renewal evaluation is completed in the EU
For reasons beyond the control of the applicants, the approvals of the active substance/product type combinations listed below were likely to expire before a decision could be taken on their renewal under the EU Biocidal Products Regulation (EU BPR).
To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approvals until the following dates. This affects Northern Ireland (NI):
28 February 2024:
28 February 2024:
30 June 2024:
31 July 2024:
30 September 2024:
30 November 2024:
31 January 2025:
If you want to supply new biocidal products containing these active substances, you can still apply for EU BPR product authorisation. New products (including new trade names) must not be supplied in NI until product authorisation is granted.
HSE (GB) will provide separate updates on the renewal decisions when relevant.